Skip to main content

Table 1 Basic characteristic of the study groups

From: Quantitative assessment of left ventricular longitudinal function and myocardial deformation in Duchenne muscular dystrophy patients

 

DMD n = 51

Controls n = 18

P value

Age (years)

14.7 ± 6.1

17.5 ± 2.9

0.064

Weight (kg)

49.1 ± 20.4

68.1 ± 10.5

4.10–4

Height (cm)

149 ± 19

177 ± 18

4.10–8

Dyspnoea (n (%))

7 (13.7%)

0 (0%)

0.18

BMI (kg/m2)

21.3 ± 5.6

21.8 ± 2.2

0.73

Hypertension (n (%))

3 (5.9%)

0 (0%)

0.56

Diabetes (n (%))

0 (0%)

1 (5.6%)

0.26

Corticosteroids (n (%))

22 (44.0%)

0 (0%)

3.10–4

ACE-inhibitors (n (%))

18 (36.0%)

0 (0%)

2.10–3

ARBs (n (%))

2 (4.0%)

0 (0%)

1.00

β-blockers (n (%))

8 (16.0%)

0 (0%)

0.10

Diuretics (n (%))

3 (6.0%)

0 (0%)

0.56

  1. Continuous variables are expressed as the mean ± standard deviation, binary variables as count (percentage). The p values refer to the t-test in the case of continuous variables or to Fisher exact test in binary variables. P-values < 0.05 are marked in bold.
  2. DMD, Duchenne muscular dystrophy; BMI, body mass index; ACE, angiotensin converting enzyme; ARB, angiotensin receptor blockers